Fujifilm says will invest $2 billion in new large-scale cell culture production site in U.S

This post was originally published on this site

The new plant will help accelerate growth of the Japanese company’s biopharmaceutical contract development and manufacturing business (CDMO), Fujifilm said in a release. The new site will be built near an existing Fujifilm site with production expected to start in the spring of 2025.